Pathogenesis of radiation-induced capsular contracture in tissue expander and implant breast reconstruction

Plastic and Reconstructive Surgery

Volumn 125, Issue 2, 2010, Pages 437-445

  Lipa, Joan E ^a,b,c,d,e   Qiu, Wei ^a,b,c,d,e   Huang, Ning ^a,b,c,d,e   Alman, Benjamin A ^a,b,c,d,e   Pang, Cho Y ^a,b,c,d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Hospital for Sick Children ^*

^c HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^d University of Toronto   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CYCLOOXYGENASE 2; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; WNT1 PROTEIN; WNT1 PROTEIN, HUMAN;

ARTICLE; BIOPSY; BREAST; BREAST ENDOPROSTHESIS; BREAST RECONSTRUCTION; BREAST TUMOR; CONTRACTURE; FEMALE; FIBROBLAST; FIBROSIS; HUMAN; IMPLANT; MASTECTOMY; METABOLISM; METHODOLOGY; NECROSIS; PATHOLOGY; POSTOPERATIVE COMPLICATION; RADIATION EXPOSURE; RADIOTHERAPY; SIGNAL TRANSDUCTION; SKIN;

BETA CATENIN; BIOPSY; BREAST; BREAST IMPLANTS; BREAST NEOPLASMS; COLLAGEN TYPE I; COLLAGEN TYPE III; CONTRACTURE; CYCLOOXYGENASE 2; FEMALE; FIBROBLASTS; FIBROSIS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MAMMAPLASTY; MASTECTOMY; NECROSIS; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY; SIGNAL TRANSDUCTION; SKIN; TISSUE EXPANSION DEVICES; WNT1 PROTEIN;

EID: 76949102479     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181c82d05     Document Type: Article

References (27)

1. Spear SL, Onyewu C. Staged breast reconstruction with saline-filled implants in the irradiated breast: Recent trends and therapeutic implications. Plast Reconstr Surg. 2000;105: 930.
2. Delanian S. Striking regression of radiation-induced fibrosis by a combination of pentoxifylline and tocopherol. Br J Radiol. 1998;71:892.
3. Delanian S, Lefaix JL. Complete healing of severe osteoradionecrosis with treatment combining pentoxifylline, tocopherol and clodronate. Br J Radiol. 2002;75:467.
4. Delanian S, Porcher R, Balla-Mekias S, Lefaix JL. Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol. 2003;21:2545.
5. Delanian S, Porcher R, Rudant J, Lefaix JL. Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis. J Clin Oncol. 2005;23:8570.
6. Xavier S, Piek E, Fujii M, et al. Amelioration of radiation-induced fibrosis: Inhibition of transforming growth factor-beta signaling by halofuginone. J Biol Chem. 2004;279:15167.
7. Flanders KC. Smad3 as a mediator of the fibrotic response. Int J Exp Pathol. 2004;85:47.
8. Alman BA, Li C, Pajerski ME, et al. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol. 1997;151:329.
9. Abraham SC, Reynolds C, Lee JH, et al. Fibromatosis of the breast and mutations involving the APC/beta-catenin pathway. Hum Pathol. 2002;33:39.
10. Howard JC, Varallo VM, Ross DC, et al. Elevated levels of beta-catenin and fibronectin in three-dimensional collagen cultures of Dupuytren's disease cells are regulated by tension in vitro. BMC Musculoskelet Disord. 2003;4:16.
11. Varallo VM, Gan BS, Seney S, et al. Beta-catenin expression in Dupuytren's disease: Potential role for cell-matrix interactions in modulating beta-catenin levels in vivo and in vitro. Oncogene 2003;22:3680.
12. Cheon SS, Cheah AY, Turley S, et al. beta-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds. Proc Natl Acad Sci USA. 2002; 99:6973.
13. Cheon S, Poon R, Yu C, et al. Prolonged beta-catenin stabilization and tcf-dependent transcriptional activation in hyperplastic cutaneous wounds. Lab Invest. 2005;85:416.
14. Silkstone D, Hong H, Alman BA. β-catenin in the race to fracture repair: In it to Wt. Nat Clin Pract Rheumatol. 2008; 4:413-419.
15. Poon R, Smits R, Li C, et al. Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor). Oncogene 2001;20:451.
16. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt singaling in cancer. Biochim Biophys Acta 2003;1653:1.
17. Rosato RM, Dowden RV. Radiation therapy as a cause of capsular contracture. Ann Plast Surg. 1994;32:342.
18. Vandeweyer E, Deraemaecker R. Radiation therapy after immediate breast reconstruction with implants. Plast Reconstr Surg. 2000;106:56.
19. Mark RJ, Zimmerman RP, Greif JM. Capsular contracture after lumpectomy and radiation therapy in patients who have undergone uncomplicated bilateral augmentation mammoplasty. Radiology 1996;200:621.
20. Guenther JM, Tokita KM, Giuliano AE. Breast-conserving surgery and radiation after augmentation mammoplasty. Cancer 1994;73:2613.
21. Handel N, Lewinsky B, Jensen JA, Silverstein MJ. Breast conservation therapy after augmentation mammaplasty: Is it appropriate? Plast Reconstr Surg. 1996;98:1216.
22. Cheon SS, Nadesan P, Poon R, Alman BA. Growth factors regulate beta-catenin-mediated TCF-dependent transcriptional activation in fibroblasts during the proliferative phase of wound healing. Exp Cell Res. 2004;293:267.
23. Letamendia A, Labbe E, Attisano L. Transcriptional regulation by Smads: Crosstalk between the TGF-beta and Wnt pathways. J Bone Joint Surg (Am.) 2001;83:S31.
24. Tian YC, Phillips AO. Interaction between the transforming growth factor-β type II receptor/Smad pathway and β-catenin during transforming growth factor-β1-mediated adherens junction disassembly. Am J Pathol. 2002;160:1619.
25. Flanders KC, Major CD, Arabshahi A, et al. Interference with transforming growth factor-beta/Smad3 signaling results in accelerated healing of wounds in previously irradiated skin. Am J Pathol. 2003;163:2247.
26. Flanders KC, Sullivan CD, Fujii M, et al. Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. Am J Pathol. 2001;160:1057.
27. McAllister SE, Moses MA, Jindal K, et al. Na+/H+ exchange inhibitor Cariporide attenuates skeletal muscle infarction when administered before ischemia or reperfusion. J Appl Physiol. 2009;106:20-28.